Emmes, a Rockville, MD-based biotech company, received an investment from Behrman Capital.
The amount of the deal was not disclosed.
The company intends to use the funds to expand and strengthen its service offerings and international presence.
Led by Dr. Anne Lindblad, president and CEO, Emmes is a contract research organization that works side-by-side with researchers to tackle challenges that have an impact on public health throughout the world.
The company offers:
– Clinical Research Services,
– Specialty Services,
– Bioinformatics & IT Solutions, and
– a unified clinical trials platform.
The company, which serves National Institutes of Health (NIH), other government departments, representative non-profits, universities and other organizations, has two offices in Maryland, one in Northern Virginia, one in Canada, and two in India.